Training | 2016.05.06
ProMIS Neurosciences Announces Identification of a Fourth Novel Therapeutic Target for Alzheimer’s Disease
Novel target is fourth in a series of potential targets on strains of misfolded Amyloid beta, implicated in the development and progression of Alzheimer’s
(PRWeb May 05, 2016)
Read the full story at http://www.prweb.com/releases/2016/05/prweb13388670.htm
For more information, please visit
http://www.prweb.com/releases/2016/05/prweb13388670.htm
